1. Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors
by Manabu Wakamatsu, Seitaro Terakura, Kazuteru Ohashi, Takahiro Fukuda, Yukiyasu Ozawa, Heiwa Kanamori, Masashi Sawa, Naoyuki Uchida, Shuichi Ota, Akiko Matsushita, Yoshinobu Kanda, Hirohisa Nakamae, Tatsuo Ichinohe, Koji Kato, Makoto Murata, Yoshiko Atsuta, and Takanori Teshima
BloodAdv
Volume 3(2):
January 22, 2019
© 2019 by The American Society of Hematology

2. Manabu Wakamatsu et al. Blood Adv 2019;3:105-115
© 2019 by The American Society of Hematology

3. Cumulative incidences of grades II to IV aGVHD with various graft sources.
Cumulative incidences of grades II to IV aGVHD with various graft sources. (A) CB. (B) Related donor. (C) Unrelated donor.
Manabu Wakamatsu et al. Blood Adv 2019;3:
© 2019 by The American Society of Hematology

4. Forest plot showing the different impact of ATG on transplant outcome across different donor types.
Forest plot showing the different impact of ATG on transplant outcome across different donor types. Hazard ratios are shown by the middle line in the box, and 95% confidence interval ranges are indicated by the line at both ends.
Manabu Wakamatsu et al. Blood Adv 2019;3:
© 2019 by The American Society of Hematology

5. Cumulative incidence of NRM with various graft sources.
Cumulative incidence of NRM with various graft sources. (A) CB. (B) Related donor. (C) Unrelated donor.
Manabu Wakamatsu et al. Blood Adv 2019;3:
© 2019 by The American Society of Hematology

6. Probability of GRFS and OS with various graft sources.
Probability of GRFS and OS with various graft sources. (A,D) CB. (B,E) Related donor. (C,F) Unrelated donor.
Manabu Wakamatsu et al. Blood Adv 2019;3:
© 2019 by The American Society of Hematology